✦ LIBER ✦

Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma

✍ Scribed by Alan Yagoda

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 782 KB
Volume: 32
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197311)32:5<1131::aid-cncr2820320519>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Perioperative hormonal therapy in locall

Perioperative hormonal therapy in locally advanced adenocarcinoma of the prostate

✍ Sam D. Graham Jr.; Thomas E. Keane; John A. Petros; W. Holt Sanders 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

Hormonal therapy in the treatment of car

Hormonal therapy in the treatment of carcinoma of the prostate

✍ David G. McLeod 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Treatment of newly diagnosed metastatic

Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone

✍ Gerald P. Murphy; Sunmolu Beckley; Mark F. Brady; T. Ming Chu; Jean B. Dekernion 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

by the National Prostatic Cancer Project randomized newly diagnosed metastatic prostate cancer patients to DES 1 mg orally three times daily or orchiectomy; or DES, 1 mg, three times daily, plus cyclophosphamide at 1 mg/m2 iv every three weeks, or cyclophosphamide 1 g/m2 iv every three weeks plus es

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

Dose escalation of oral vinorelbine in c

Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate

✍ Niklas J. Mackler; Rodney L. Dunn; Beth Hellerstedt; Kathleen A. Cooney; Judith 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Use of rhodamine 123 in the treatment of

Use of rhodamine 123 in the treatment of the pollard iii rat prostate adenocarcinoma

✍ John A. Arcadi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Significant destruction of the Pollard 111 rat prostate adenocarcinoma was achieved by treatment with rhodamine 123 at a dosage of 15 mg/kg every other day for 33 to 38 days. Injection of tumor remnants into untreated animals produced no tumor regrowth. Our data have demonstrated rhodamine 123 to bc